Ledger.Open graph →

SEC Form D · filed January 4, 2023

Flavocure Biotech, Inc

Offering

$1.3M

Sold

$1.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BALTIMORE, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Douglas Liu · Baltimore, MDExec Henry Lowe · Baltimore, MDExec · Director Ngeh Toyang · Baltimore, MDExec · Director Justin Grant · Baltimore, MDDirector Homi Vazifdar · Larkspur, CADirector Peter Slaugh · Denver, COExec · Director Anna Bisell · Denver, COExec · Director Paul Gradeff · Denver, COExec Swen Simms · Kingston 20, L8Promoter Eric Chapman · Etobicoke, Ontario, CanadaPromoter David Traylor · Centennial, COPromoter Theresia Toyeng · Elkridge, MDPromoter Thomas Lang · Baltimore, MDExec David Brooks · Durham, NCExec Anthony Deasey · Severna Park, MDPromoter Saurabh Sewak · Winchester, MAPromoter Joseph Erigo · New York, NYExec · Director Sanjeev Krishnan · CHICAGO, ILExec · Director Chuck Templeton · CHICAGO, ILExec Farooq Abbasi · New York, NYDirector Swen Simms · Kingston 20, L8Promoter Eric Chapman · Etobicoke, Ontario, CanadaPromoter David Traylor · Centennial, COPromoter Theresia Toyeng · Elkridge, MDPromoter Thomas Lang · Dublin, OHExec David Brooks · Stuart, FLExec Anthony Deasey · Severna Park, MDPromoter Saurabh Sewak · Winchester, MAPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗